Several studies reported that in patients with high-grade ovarian serous carcinoma this response is dysregulated and low levels of glutathione peroxidase 3 were recorded in patients with metastatic or relapsed ovarian cancer [44,45]. Here, GPX3 is linked to ovarian carcinoma.